Literature DB >> 26941545

Laparoscopic Radical Prostatectomy Alone or With Laparoscopic Herniorrhaphy.

Orcun Celik1, Murat Akand2, Gokhan Ekin1, Ibrahim Duman3, Yusuf Ozlem Ilbey1, Tibet Erdogru4.   

Abstract

BACKGROUND AND OBJECTIVES: Prostate cancer and inguinal hernia are common health issues in men aged more than 50 years. Recently, more data are accumulating that laparoscopic radical prostatectomy (LRP) and laparoscopic inguinal hernia repair (LIHR) can be performed in the same operation. The purpose of this study was to compare patients who underwent simultaneous extraperitoneal LRP (E-LRP) and LIHR with control patients who underwent only E-LRP in a matched-pairs design.
METHODS: Medical records of 215 patients were evaluated, and 20 patients who underwent E-LRP+LIHR were compared with 40 patients who underwent only E-LRP in a matched-pairs analysis. Preoperative clinical parameters (age, body mass index, prostate-specific antigen, clinical stage, Gleason score of the prostate biopsy, and prostate volume) and operative data (operation time, duration of catheterization, length of hospital stay, estimated blood loss, time to perform the anastomosis and its quality, and the percentage of patients with bilateral lymphadenectomy) were evaluated, as well as postoperative parameters (pathological stage, Gleason score, specimen weight, follow-up duration, biochemical recurrence, complication rates, and duration of postoperative analgesic treatment).
RESULTS: No statistically significant differences were found in the preoperative and operative parameters between the 2 study groups. Pathological parameters and the follow-up period and complication rates were similar between the 2 groups.
CONCLUSION: Performing LIHR and E-LRP during the same operation is safe and feasible in the treatment of patients with prostate cancer and inguinal hernia.

Entities:  

Keywords:  Extraperitoneal radical prostatectomy; Herniorrhaphy; Inguinal hernia; Laparoscopy

Mesh:

Substances:

Year:  2015        PMID: 26941545      PMCID: PMC4756355          DOI: 10.4293/JSLS.2015.00090

Source DB:  PubMed          Journal:  JSLS        ISSN: 1086-8089            Impact factor:   2.172


INTRODUCTION

Prostate cancer (PCa) is a major health threat for men, being the second greatest cause of cancer deaths among men in Europe and in our country.[1,2] The incidence of PCa has a tendency to increase and to be more common in men aged more than 50 years.[1] The lifetime prevalence rate of inguinal hernia (IH) in men aged more than 45 years ranges between 28.0 and 39.7%.[3] With this high prevalence rate, it is reasonable to assume that men who have localized PCa and are candidates for radical prostatectomy (RP) have the same risk of IH as age-matched men in the general population at the time of operation. Various IH repair (IHR) techniques have been described over time. This operation can be performed in an open or laparoscopic fashion, with or without the application of mesh.[4] Either biodegradable or synthetic mesh is preferred in IHR techniques that include placement of mesh.[5] There are 2 recognized methods of laparoscopic IHR (LIHR): total extraperitoneal repair (TEP) and transabdominal preperitoneal repair (TAPP).[4,6] The recurrence of hernia and postoperative pain tends to be less after TEP.[7] Laparoscopic radical prostatectomy (LRP) has gained importance in the treatment of localized PCa after Guillonneau et al[8] published their technique. Over time, extraperitoneal LRP (E-LRP) has been shown to be an effective and safe method for the management of PCa, with some advantages over the transperitoneal approach.[9,10] Although both transperitoneal and extraperitoneal techniques can be combined with LIHR, E-LRP is more advantageous, as it avoids the contact of the mesh with the bowel, thus markedly reducing the risk of adhesions. We regard the TEP+E-LRP combination as preferable in patients with an IH and localized PCa. We used a matched-pairs design to compare results in patients who underwent simultaneous E-LRP and LIHR (E-LRP+LIHR) with those in a control group who underwent only E-LRP.

MATERIALS AND METHODS

From March 2004 through November 2013, 340 patients underwent LRP by the same surgeon (T.E.). Of these patients, 85 had transperitoneal LRP (T-LRP) and 255 had E-LRP. After excluding the first 40 cases of E-LRP as constituting the learning curve, we evaluated 215 patients who underwent the procedure. A further 20 patients who underwent E-LRP+LIHR were evaluated and compared with 40 who underwent only E-LRP, in a matched-pairs analysis. In the preoperative evaluation, the inguinal canals were examined by the same surgeon (T.E.) in patients maintained in the upright position during a Valsalva maneuver. For the patients with reducible IHs, regardless of defect size, TEP hernia repair was performed after RP was completed. Irreducible IHs were not managed with LIHR. The technique used for E-LRP has been published.[11] After a transverse incision 1 cm below the umbilicus and a sharp incision of the rectus fascia, the Retzius space was accessed with blunt digital dissection between the rectus muscle and the posterior sheath of its fascia. Located 10 cm lateral to the infraumbilical incision, both medial 10-mm trocars were inserted into the preperitoneal space under digital control. After a 12-mm trocar was inserted into the infraumbilical incision, all trocars were fixed, and the wounds were closed with interrupted sutures. The lateral fusion of the fascia transversalis was incised below the epigastric arteries to reach Borgros' space, and 2 additional 5-mm trocars were inserted laterally under laparoscopic control. After high transection of the urachus and division of both lateral umbilical ligaments, the sixth trocar was placed in the right lower abdomen after the Retzius space was dissected completely. When indicated, a bilateral lymphadenectomy consisting of the obturator and internal and external iliac lymph nodes was performed. After the endopelvic fascia was incised on both sides, the deep dorsal vein complex was controlled with sutures and divided. The prostatic apex was dissected meticulously, and the neurovascular bundles were preserved in the patients, as indicated. The division of the urethra was followed by the posterior dissection of the prostate and the seminal vesicles and vas deferens. The prostate was completely freed by division of the cranial pedicles and inserted into an organ bag. A vesicourethral anastomosis was created with running sutures and checked for watertightness. The hernia sac was mobilized and dissected from the spermatic cord structures (). The defect in the IH area was measured with a flexible plastic tape, a portion of polypropylene mesh with approximate dimensions of 8–10 × 10–12 cm was prepared, and a 6-cm vertical cut was made in the mesh extracorporeally to accommodate the spermatic cord (). To facilitate placement, the mesh was rolled up and introduced through a 12-mm trocar. The unfolded mesh was positioned around the spermatic structures to cover the visible defect and anchored to the abdominal wall with 4 sutures on each corner ( and ). Dissection of the hernia sac with a laparoscopic peanut. Measurement of the hernia defect with a flexible plastic ruler. The polypropylene mesh prepared in accordance with the defect is placed around the cord. Final appearance of the properly placed mesh around the cord structures. Operation time, duration of catheterization, length of hospital stay, preoperative and postoperative hemoglobin values, estimated blood loss (EBL), time to perform the anastomosis and its quality, percentage of patients who underwent bilateral lymphadenectomy, and duration of analgesic treatment were recorded. The soundness of the anastomosis was evaluated by infusing 200 mL saline into the bladder through a urethral catheter after the vesicourethral anastomosis was completed and was classified into 4 groups: no leak, mild leak, moderate leak, and severe leak. Postoperative parameters were evaluated, including pathologic stage and Gleason score, specimen volume, follow-up duration, and biochemical recurrence rates. Perioperative complications were collected and classified according to the modified Clavien-Dindo system.[12] All patients had given written informed consent before the surgery for the use of the collected data at any time. The principles of the Declaration of Helsinki for research involving human subjects were followed during the study, and the confidentiality of the patients' data was guaranteed. The Institutional Ethics Committee approved the study. Numeric data were compared by independent t test, and the χ2 test was used for the comparison of the nonnumeric outcomes. P < 0.05 was considered statistically significant. All statistical analyses were performed with the IBM Statistical Package for Social Sciences (SPSS) Software, version 22 (Armonk, New York, USA).

RESULTS

The patients' demographics and the operative and pathology results are presented in . No statistically significant difference was determined for age, body mass index (BMI), preoperative prostate-specific antigen (PSA) level, transrectal ultrasonography–determined prostate weight, and clinical stage between the 2 groups. Regarding the pathology findings (), Gleason score sums of the preoperative prostate biopsy and the specimen after prostatectomy, pathological stage, and specimen weights were not significantly different among the groups. Operation time, preoperative and postoperative hemoglobin values, EBL, duration of catheterization, hospital length of stay, time to perform the anastomosis and its quality classification, percentage of patients with bilateral lymphadenectomy, and duration of analgesic treatment were also similar between the 2 groups. Demographic, Operative, and Pathologic Results of E-LRP and E-LRP+LIHR Data are expressed as the mean ± SD or n (%). Delta Hb: decrease in hemoglobin; GS, Gleason score; PSA, prostate-specific antigen; TRUS, transrectal ultrasonography. Perioperative complications according to the Clavien-Dindo classification (minor: grades 1 and 2; major: grades 3, 4, and 5)[12] are shown in . No lymphoceles were observed in either group. All patients in both groups had similar follow-up duration and biochemical recurrence rate during this period. None of the patients in the E-LRP+LIHR group had a recurrence of IH during the follow-up time. Perioperative Complications According to the Clavien-Dindo Classification[12] Data were collected at the follow-up of patients in the E-LRP and E-LRP+LIHR groups and are expressed as the mean ± SD or n (%). N/A, not applicable.

DISCUSSION

RP is the treatment of choice with curative intent in PCa, and the use of LRP has gradually risen after Guillonneau et al[8] standardized the technique. Although the laparoscopic procedure carries a steep learning curve and a large number of operations is necessary to gain enough experience, experienced surgeons have reported promising results, with oncological and functional outcomes that are comparable with those of open surgery.[10] Although E-LRP is somewhat disadvantageous because of its narrower working space, it has gained acceptance among some surgeons, as it involves no contact with the bowel. E-LRP can be performed efficaciously and safely without a significant difference noted in the oncological results when compared with those of T-LRP.[11] IH is a common problem in men aged more than 50 years, and IHR is the most frequently performed operation in general surgery. The incidence of subclinical IH was reported between 10 and 33%, whereas it was found to be 20% in autopsy studies.[13,14] The chance that a man will undergo an IHR during his life is 27%.[15] In a recent study evaluating 5870 men in Rotterdam, the 20-year cumulative incidence of having an IH was 14%.[16] When the probability of coexistence of these 2 common conditions is combined with the common observation that RP becomes more difficult after IHR, some surgeons recommend screening for PCa in all men who must undergo an IHR and vice versa.[17] The potential risk factors including older age, lower BMI, bladder neck contracture, and a history of IH have been reported to be associated with IH after RP.[18,19] Several studies have shown that the incidence of IH increases in men who have undergone RP.[15,18,20-22] Sekita et al[15] found that the incidence of IH is higher after open simple prostatectomy and retropubic RP (RRP) when compared with that occurring after transurethral resection of the prostate (TURP). Although some researchers have stated that there is no difference in the incidence of IH between RRP and LRP,[19,21] in a recent study, Nilsson et al[22] reported that the incidence is increased in RRP versus that in minimally invasive RP (traditional LRP and robot-assisted LRP). Yoshimine et al[23] concluded that the incidence of IH is higher in E-LRP than in T-LRP. Although there are conflicting conclusions about the feasibility of performing RRP and LRP after IHR, Katz et al[24] and Erdogru et al[25] showed that both operations can be performed successfully but pose increased complexity. Peeters et al[26] observed that RRP after preperitoneal IHR is more difficult to perform and is associated with a longer duration of hospitalization and less adequate lymphadenectomy for intermediate- and high-risk PCa. In their recent meta-analysis of 7497 patients from 11 studies, Picozzi et al[27] concluded that previous LIHR with mesh placement can complicate subsequent RP, regardless of the technique (open vs laparoscopic vs robotic), in terms of bleeding, catheterization time, and extent of pelvic lymphadenectomy. On the contrary, Spernat et al[28] reported that RP (open, laparoscopic, or robotic) is not contraindicated and can be performed safely after LIHR; however, lymph node dissection cannot be performed in 50% of patients because of adhesions, and this possibility may lead to inadequate staging and treatment. There are several studies in the literature emphasizing that simultaneous repair of IHs detected during LRP is easy, and therefore, an HR should not be postponed. In their series consisting of 93 cases of preperitoneal IHRs performed during endoscopic extraperitoneal RP, Do et al[29] concluded that neither the complication rates nor the oncological and functional outcomes were influenced by the simultaneous performance of the procedures. Teber et al[30] established that a simultaneous LIHR with prosthetic mesh during LRP results in a statistically significant increase in the duration of the operation and the need for analgesics, although no significant differences were recorded in complication rates and positive surgical margins. On the other hand, Gözen et al[31] found that simultaneous LIHR does not affect the duration of the operation or complication rates and pain levels after E-LRP. In the present study, we recorded a mean operative time of 195 and 176 minutes for groups with and without a simultaneous LIHR, respectively, although this 19-minute increase in favor of the repair group was not statistically significant. There are 2 possible explanations for this result. We can conclude that simultaneous LIHRs can be performed by an experienced surgeon without a significant increase in operation time. On the other hand, these results may be due to the small sample size. No statistically significant difference was observed in any of the other parameters between the 2 groups, which appears to be consistent with data reported in the literature. Our results for complication rates and duration of the operation were similar to those of Gözen et al.[31] Although lymphadenectomy during E-LRP has a tendency to cause more lymphoceles than the transperitoneal approach, we did not observe this complication in either study group. Development of a lymphocele can also affect the rate of other complications (eg, mesh-related infection). Performing an LIHR with prosthetic mesh during an LRP raises concerns about infection due to urine leakage from the vesicourethral anastomosis. LIHR has a significantly lower incidence of infection and inguinal hematoma when compared to open surgery. The incidence of mesh-associated infection in LIHR is very low (range, 0–0.17%), perhaps because the contact of mesh with the skin is prevented when the mesh passes through the trocar.[4,29,31] Our mesh-related infection incidence of 0% is consistent with that reported in the literature. This study has some limitations that should be noted. First, a relatively small number of patients was evaluated in each group, which may affect the reliability of the statistical analysis. We think that using a matched-pairs analysis compensated for this deficit to some degree. Second, a retrospective study instead of a prospective randomized one provides a lower level of evidence. A prospective randomized study with a high case volume would prevent selection bias and provide much more accurate results. Third, no information was available on the dose of the analgesic medications (narcotic or nonnarcotic) used in each group. As the study was retrospective, only data about the duration of analgesic treatment could be gathered from the progress notes. Although a slightly increased analgesic dose was observed in the E-LRP+LIHR group (data not shown), it was not clear why nor was the information suitable for statistical analysis, as data were missing in some patients' charts. Another limitation is the absence of data about the number of lymph nodes removed. It was not possible to make a comparison between the groups, as the data were not reported for every patient. The lack of centralized evaluation by a single pathologist may have contributed to this problem.

CONCLUSION

Evaluating patients with PCa who will undergo E-LRP is important, as an IH can be efficiently and safely treated by simultaneous LIHR. Thus, the need for an extra operation with an additional financial burden on the health system can be avoided.
Table 1.

Demographic, Operative, and Pathologic Results of E-LRP and E-LRP+LIHR

E-LRP+LIHR (n = 20)E-LRP Only (n = 40)P
Age (years)65.3 ± 3.865.1 ± 3.7.846
BMI (kg/m2)27.25 ± 3.8427.32 ± 3.09.938
PSA (ng/mL)8.95 ± 4.509.36 ± 6.49.800
TRUS prostate weight (g)52.2 ± 14.453.1 ± 13.8.823
Clinical stage.327
    T116 (80)29 (72.5)
    T24 (20)11 (27.5)
Biopsy GS6.356.48.867
Operation time (minutes)195.9 ± 35.6176.4 ± 69.9.157
Catheterization time (days)7.1 ± 1.17.9 ± 2.8.141
Hospitalization time (days)2.7 ± 0.93.3 ± 2.1.176
Duration of analgesic treatment (days)
    Narcotic1.4 ± 0.41.2 ± 0.3.723
    Nonnarcotic1.9 ± 0.61.6 ± 0.7.691
EBL (mL)265.3 ± 133.8275.8 ± 129.2.707
Preoperative Hb (g/dL)14.3 ± 1.414.0 ± 1.0.394
Postoperative Hb (g/dL)12.1 ± 3.811.9 ± 1.1.744
Preoperative Hb (g/dL)14.3 ± 1.414.0 ± 1.0.394
Postoperative Hb (g/dL)12.1 ± 3.811.9 ± 1.1.744
Delta Hb (g/dL)2.1 ± 1.12.0 ± 1.2.616
Anastomosis time (minutes)25.7 ± 3.826.3 ± 4.1.592
Anastomosis quality.103
    No leak17 (85)36 (90)
    Mild leak3 (15)2 (5)
    Moderate leak0 (0)1 (2.5)
    Severe leak0 (0)1 (2.5)
Pathological stage.401
    T214 (70)32 (80)
    T36 (30)8 (20)
Pathologic GS6.576.78.812
Specimen weight (g)49.2 ± 10.452.4 ± 12.9.903
Bilateral lymphadenectomy11 (55)16 (40).271

Data are expressed as the mean ± SD or n (%). Delta Hb: decrease in hemoglobin; GS, Gleason score; PSA, prostate-specific antigen; TRUS, transrectal ultrasonography.

Table 2.

Perioperative Complications According to the Clavien-Dindo Classification[12]

E-LRP+LIHR (n = 20)E-LRP Only (n = 40)P
Minor complications, Grades 1–26 (30)14 (35).893
    Grade 1, n49
    Grade 2, n25
Major complications, Grades 3–50 (0)1 (2.5).658
    Grade 3a01
Follow-up duration (months)40.6 ± 11.548.2 ± 12.8.153
Biochemical recurrence1 (5)3 (7.5).264
Recurrence of inguinal hernia0 (0)N/AN/A

Data were collected at the follow-up of patients in the E-LRP and E-LRP+LIHR groups and are expressed as the mean ± SD or n (%). N/A, not applicable.

  30 in total

Review 1.  Partially or completely absorbable versus nonabsorbable mesh repair for inguinal hernia: a systematic review and meta-analysis.

Authors:  Sheraz R Markar; Alan Karthikesalingam; Fahreyar Alam; Tjun Y Tang; Stewart R Walsh; Umar Sadat
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2010-08       Impact factor: 1.719

2.  Concurrent radical retropubic prostatectomy and Lichtenstein inguinal hernia repair through a single modified Pfannenstiel incision: a 3-year experience.

Authors:  Murugesan Manoharan; Sachin Vyas; Motoo Araki; Alan M Nieder; Mark S Soloway
Journal:  BJU Int       Date:  2006-08       Impact factor: 5.588

Review 3.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

4.  Hernia repair during endoscopic extraperitoneal radical prostatectomy: outcome after 93 cases.

Authors:  Minh Do; Evangelos N Liatsikos; Panagiotis Kallidonis; Andrew W Wedderburn; Anja Dietel; Kevin J Turner; Jens-Uwe Stolzenburg
Journal:  J Endourol       Date:  2011-03-18       Impact factor: 2.942

5.  Case-matched analysis of outcome after open retropubic radical prostatectomy in patients with previous preperitoneal inguinal hernia repair.

Authors:  E Peeters; S Joniau; H Van Poppel; M Miserez
Journal:  Br J Surg       Date:  2011-12-20       Impact factor: 6.939

6.  Risk factors for inguinal hernia in middle-aged and elderly men: results from the Rotterdam Study.

Authors:  Barry de Goede; Lucas Timmermans; Bob J H van Kempen; Frank J A van Rooij; Geert Kazemier; Johan F Lange; Albert Hofman; Johannes Jeekel
Journal:  Surgery       Date:  2015-01-14       Impact factor: 3.982

7.  Oncologic outcome after extraperitoneal laparoscopic radical prostatectomy: midterm follow-up of 1115 procedures.

Authors:  Alexandre Paul; Guillaume Ploussard; Nathalie Nicolaiew; Evanguelos Xylinas; Norman Gillion; Alexandre de la Taille; Dimitri Vordos; Andras Hoznek; René Yiou; Claude Clément Abbou; Laurent Salomon
Journal:  Eur Urol       Date:  2009-09-17       Impact factor: 20.096

8.  Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection.

Authors:  Maxine Sun; Giovanni Lughezzani; Ahmed Alasker; Hendrik Isbarn; Claudio Jeldres; Shahrokh F Shariat; Lars Budäus; Jean-Baptiste Lattouf; Luc Valiquette; Markus Graefen; Francesco Montorsi; Paul Perrotte; Pierre I Karakiewicz
Journal:  J Urol       Date:  2010-01-18       Impact factor: 7.450

9.  Endoscopic extraperitoneal radical prostatectomy: evolution of the technique and experience with 2400 cases.

Authors:  Jens-Uwe Stolzenburg; Panagiotis Kallidonis; Do Minh; Anja Dietel; Tim Häfner; Dimitris Dimitriou; Abdulrahman Al-Aown; Iason Kyriazis; Evangelos N Liatsikos
Journal:  J Endourol       Date:  2009-09       Impact factor: 2.942

10.  [Laparoscopic radical prostatectomy. Preliminary evaluation after 28 interventions].

Authors:  B Guillonneau; X Cathelineau; E Barret; F Rozet; G Vallancien
Journal:  Presse Med       Date:  1998-10-17       Impact factor: 1.228

View more
  3 in total

Review 1.  Extraperitoneal Robot-Assisted Radical Prostatectomy: Indications, Technique and Outcomes.

Authors:  Alice Semerjian; Christian P Pavlovich
Journal:  Curr Urol Rep       Date:  2017-06       Impact factor: 3.092

2.  Robotic radical prostatectomy with concomitant repair of inguinal hernia: is it safe?

Authors:  Travis Rogers; Eduardo Parra-Davila; Flavio Malcher; Carlos Hartmann; Bernardo Mastella; Guiherme de Araújo; Gabriel Ogaya-Pinies; Carlos Ortiz-Ortiz; Eduardo Hernandez-Cardona; Vipul Patel; Leandro Totti Cavazzola
Journal:  J Robot Surg       Date:  2017-08-22

Review 3.  Outcomes of Minimally Invasive Inguinal Hernia Repair at the Time of Robotic Radical Prostatectomy.

Authors:  Francois G Soto-Palou; Ricardo F Sánchez-Ortiz
Journal:  Curr Urol Rep       Date:  2017-06       Impact factor: 3.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.